U.S. FDA Approves Takeda’s Drug for Post-Transplant CMV Infection

The U.S. Food and Drug Administration said on Tuesday it had approved Takeda Pharmaceutical Co Ltd’s drug for a common type of viral infection occurring in patients after organ transplant. Read More